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THE alveolar  macrophage  (AM)  secretes  interleukin
1b (IL-1b ), tumour  necrosis factor-a (TNF-a ),  inter-
leukin-6 (IL-6)  and  interleukin-8  (IL-8), all  of  them
inflammatory cytokines involved in the pathogenesis
of many lung diseases. The aim of the present work
was to evaluate the basal and stimulated secretion of
these  cytokines  by  human  AMs.  Human  AMs  were
collected by bronchoalveolar lavage (BAL) from four
healthy controls and 13 patients with diffuse inter-
stitial lung disease (five cases of sarcoidosis, three of
hypersensitivity  pneumonitis and five of idiopathic
pulmonary fibrosis). AMs were cultured in the pres-
ence or absence of different concentrations of lipopo-
lysaccharide  (LPS),  phorbolmyristate  and  gamma-
interferon.  IL-1b ,  TNF-a ,  IL-6  and  IL-8  levels  were
measured in BAL fluid and culture supernatant using
specific  enzyme-linked immunosorbent assays. The
substance found to stimulate the secretion of inflam-
matory cytokines to the greatest extent was LPS at a
concentration of 10m g/ml. Regarding the secretion of
IL-1b , four observations were of interest: basal secre-
tion was very low; LPS exerted a potent stimulatory
effect;  considerable  within-group  variability  was
observed; and there were no significant differences in
the comparisons among groups. With respect to TNF-
a secretion, the results were similar. The only striking
finding was the higher basal secretion of this cyto-
kine  with  respect  to  that  of  IL-1b .  Regarding  the
secretion of IL-6, the same pattern followed by TNF-a
was found. However, it should be stressed that the
increase induced by LPS was smaller than in the two
previous cytokines. Regarding the secretion of IL-8,
three findings were patent: the strong basal secretion
of this cytokine; the moderate increase induced by
LPS;  and  the  existence  of  significant  differences
among  the  different  groups  with  respect  to  the
stimulated secretion of this cytokine, which reached
maximum values in patients with idiopathic pulmo-
nary  fibrosis.  Finally,  it  should  be  noted  that  the
pattern of cytokines observed in the BAL fluid was
similar  to  that  found in cultured  AM supernatants.
The pattern  of inflammatory cytokine  secretion by
AMs  differs  from  that  of  other  cells  of  the  mono-
nuclear phagocyte system (MPS). In this sense. AMs
secrete  low  amounts  of  IL-1,  moderate  amounts  of
TNF-a and IL-6, and high quantities of IL-8. Adherence
is  an  important  stimulus  in  the  secretion  of  these
molecules  and  LPS  elicits  an  increased  secretion
inverse to the basal secretion. There is considerable
individual variability  in  the  secretion of  inflamma-
tory cytokines by the AMs of patients with interstitial
lung disease and the AMs of these patients are primed
in  vivo for  the  secretion  of  these  cytokines.  The
results  of  our  study,  carried  out  in  vitro,  can  be
extrapolated to the in vivo setting.
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The alveolar macrophage (AM) is the main representa-
tive of the mononuclear phagocyte system (MPS) in the
lung.1,2 Since in healthy subjects more than 90% of the
cells lining the alveolar region are AMs and since the
density of this cell line in the fluid covering the alveolar
surface is 17 3 103 cells/m l (a concentration 25-fold
higher than that of monocytes in peripheral blood),
these MPS cells represent an important sentinel system
against inhaled environmental antigens.3,4They play a
role  in  initiating  and  maintaining  an  inflammatory
response in the lower respiratory tract,5 and in global
terms they are the most abundant cells in the distal
airways in all types of interstitial lung disease (ILD).
This cell type synthesizes and secretes all the main
types of inflammatory cytokines; that is, IL-1b , TNF-a ,
IL-6 and IL-8,5,6 well-known mediators of the pulmo-
nary  inflammatory  response.6,7 Diffuse  ILDs  are  a
representative example of the pathogenic importance
of  these  cytokines,7 above  all  in  the  basic  initial
pathogenic  phenomenon  in  all  diffuse  ILDs,  i.e.
alveolitis or inflammation of the distal airways.
The aim of the present work was to evaluate the
basal and stimulated secretion of inflammatory cyto-
kines  by  human  AMs  from  healthy  controls  and
patients  with  different  types  of  diffuse  ILD.  In  an
exhaustive review of the literature we were unable to
locate any work addressing simultaneously and exclu-
sively  the  production  of  these  four  cytokines  by
human AMs in different ILDs.
Methods
Subjects
All subjects participating in the study were informed
about the nature of the procedure (bronchoscopy and
bronchoalveolar  lavage)  and  its  complications  and
written consent to participate was obtained from all
of  them.  None  of  them  smoked  or  had  received
pharmacological treatment over the 2 months prior to
the study.
Control subjects (Group 1)
For ethical reasons, the control group only included
patients subjected to diagnostic bronchoscopy, in all
cases due  to chronic cough. The  group  comprised
four subjects in which simple chest X-ray, functional
respiratory tests and the bronchoscopic study were
normal.
Sarcoidosis patients (Group 2)
This  study  population  consisted  of  five  patients.
Owing to the small number of cases the patients were
not further subclassified. Diagnosis was made based
on the following criteria: compatible clinical history
and  chest X-ray;  lung  or  peripheral  biopsy  demon-
strating  non-caseating  epithelioid  granulomas  with
giant cell formation and a coexisting morphology of
the  parenchyma  compatible  with  sarcoidosis;  no
history  of  mycobacterial,  fungal  or  parasitic  infec-
tions; no history of exposure to organic or inorganic
material  known  to  cause  granulomatous  lung  dis-
eases, and abnormal pulmonary functions with either
reduced  lung  volumes  or  impairment  in  diffusion
capacity.
Hypersensitivity pneumonitis (HP) patients
(Group 3)
This  study  population  consisted  of  three  patients.
Diagnosis was made on the basis  of  standard para-
meters:  a  documented  history  of  exposure  to  HP
antigens;  a  symptomatic  acute  episode with  chills,
fever, cough and breathlessness 4–8h after exposure
to the specific antigen; radiologic and/or functional
features  of  ILD;  serum  antibodies  against  antigens,
and transbronchial biopsy in agreement with HP.
Idiopathic pulmonary fibrosis (IPF) patients
(Group 4)
This population comprised five patients. Diagnosis of
IPF  required  the  following:  no  clinical  history  of
exposure  to  environmental  agents  known  to  cause
interstitial lung  disease; no history of  chronic  lung
infections; evidence of interstitial infiltrates at chest
X-ray;  lung  physiology  consistent  with  a  restricted
ventilatory defect, including decreased lung volume,
normal  flow  rates  and/or  decreased  single-breath
carbon monoxide diffusion test; and biopsy evidence
in  each  patient  of  interstitial  pneumonitis  with
varying  degrees  of  interstitial  fibrosis  without  evi-
dence of granulomas, vasculitis or inorganic material
as visualized by polarized light microscopy.
Recovery of alveolar macrophages
Alveolar macrophages were obtained by fibre optic
bronchoscopy  with  bronchoalveolar  lavage  (BAL).
BAL  was  performed  according  to  the  technical
recommendations and guidelines for bronchoalveolar
lavage  of  the Task  Group  on  BAL  of  the  European
Society  of  Pneumology.  Premedication  was  accom-
plished  with  intramuscular  injection  of  atropine
30min before BAL was performed. During broncho-
scopy, topical anaesthesia was administered in several
‘bolues’ with 2% lidocaine. Two hundredml of sterile
physiological  saline  solution  was  instilled  in  four
aliquots of 50ml. The site chosen for the lavage was
selected  attending  to  the  zone  with  the  highest
activity detected with other techniques, mainly chest
X-ray and gammagraphy with 67gallium; in cases with
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lobe or lingula. The fluid was recovered by manual
aspiration  with  a  syringe  and  placed  in  a  sterile
siliconized flask at 4°C.
The fluid thus obtained was filtered through two
layers of sterile surgical gauze and then centrifuged at
500g over 10min at 4°C. This procedure afforded two
fractions: the supernatant and the cellular pellet. The
cells were resuspended, depending on the size of the
cellular pellet, in 1–5ml of sterile phosphate buffered
solution. The  supernatant  from  the  BAL  fluid  was
frozen at –70°C until study. This fluid was later used
for the determination of cytokine concentrations in
selected cases.
Quantification  of  the  total  number  of  cells  was
performed using a Neubauer chamber. Cell viability
was assessed by trypan blue exclusion and differential
cell  counts  were  performed  on  Diff  Quik®-stained
glass-cover Cytospin slide preparations. In all cases,
a -naphthyl-esterase  (Sigma  Chemicals)  staining  was
performed to confirm the suitability of the differential
cell  count  for  cells  of  the  mononuclear  phagocyte
line.
Culture of alveolar macrophages
Initially, the mononuclear fraction present in the BAL
fluid  was  obtained  by  separation  with  a  Ficoll-
Hypaque  density  gradient.  The  mononuclear  cells
were resuspended in culture medium containing, as
well as commercial RPMI 1640, glutamine at 2mM,
100U  of  penicillin/ml,  100m g  of  streptomycine/ml
and 10% decomplemented fetal calf serum. Following
this, 500000 AMs diluted in complete medium were
added to each well of the culture dishes up to a total
volume of 2ml. This suspension was incubated for 2h
at 37°C in a humid atmosphere with 5% CO2 for the
macrophages to adhere. The supernatant was aspir-
ated out and designated ‘preincubation’;  this corre-
sponded  to  cell  secretion  or  elimination  in  the
absence of stimuli. In each case, the following were
added to purified macrophages diluted in complete
medium: endotoxin (LPS) at final concentrations of
100m g/ml,  10m g/ml  and 1m g/ml,  phorbolmyristate
(PMA) at final concentrations of 10–4 M, 10–5 M and
10–6 M, and human gamma-interferon at final concen-
trations of  1000U/ml,  and  100U/ml  and  100U/ml.
The  cells  were  maintained  at  37°C  in  a  humid
atmosphere with 5% CO2 for 18h. Supernatants were
centrifuged at 500g for 10min to eliminate aspirated
cells and stored at –70°C until later determination.
Contamination with endotoxin was ruled out in all
cases that were not stimulated with LPS.
Determination of cytokines
The inflammatory cytokines IL-1b , TNF-a , IL-6 and IL-
8  were  determined  by  direct  double-sandwich
enzyme-linked immunosorbent assay (ELISA) of anti-
bodies  in  all  the  fluids  from  the  BALs,  in  all  the
supernatants from the macrophage cultures,  and in
selected samples of culture medium and ‘preincuba-
tion’ medium from one case in each group (the one
with the highest secretion of cytokines in culture).
BIOTRAK®  (Amersham,  UK)  equipment  was  used;
this is specific for human IL-1b , TNF-a , IL-6 and IL-8,
with no cross-reactivity among these nor with other
cytokines, with a global variation coefficient of less
than  10%  and  the  following  respective  sensitivity
limits: 0.3pg/ml; 4.8pg/ml; 0.35pg/ml and 4.7pg/ml.
All samples were measured in duplicate. The results
were expressed in pico- or nanograms/106 AMs in the
case of the culture supernatants and in picograms/ml
in the case of the BAL fluid. None of the components
of  the  culture  medium  (RPMI  1640,  antibiotics,
glutamine  or  fetal  calf  serum)  displayed  immunor-
eactivity with the four types of cytokine studied in the
ELISA assays.
Data statistics
The  data were  summarized  as  means  and  standard
errors of means (SEM) in the different experimental
groups.  Although  all  the  samples  were  distributed
normally,  owing  to  the  low  number  of  cases  the
Wilcoxon test was used as a non-parametric test for
comparison of paired data. However, for the analysis
of global differences among groups, ANOVA was used;
where global significant differences were found the
PLSD Fisher test was employed to determine between
which groups the differences existed. In all cases a
significance level of a =0.05 was considered.
Results
Table 1 summarizes the basic data (cells recovered
and differential counts) about the cases included in
the study.
Initial release of cytokines in the absence of
stimuli
In order to determine whether AMs release inflamma-
tory cytokines in the absence of exogenous stimuli or
after prolonged culture, cytokines were measured in
the supernatant of mononuclear cells incubated for
2h for macrophage adherence to occur. Although the
aim of this determination was to assess spontaneous
release of cytokines by AM, it should be noted that
under these conditions cytokines produced by lym-
phocytes and/or the actual adherence of AMs to the
polystyrene may act as modulatory factors.
The  results  obtained  in  the  index  cases  of  each
group  afforded  interesting  data.  First,  none  of  the
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of  interleukin  1b .  The  spontaneous  release  of
TNF-a ranged  between  129  and  996pg/106 AMs,
being  maximum  in  the  group  of  patients  with
idiopathic  pulmonary  fibrosis.  The  relationship
between  basal  secretion  after  prolonged  culture
(18h)  and initial  spontaneous release was  on aver-
age  4:1,  this  ratio  being  lower  in  the  group  of
patients  with  idiopathic  pulmonary  fibrosis  (ratio,
2.3:1).  In  the  case  of  IL-6,  initial  spontaneous
release  ranged  between  20  and  421pg/106 AMs,
being  maximum  in  the  group  with  idiopathic  pul-
monary  fibrosis. The  ratio  between  basal  secretion
in  culture  and  initial  spontaneous  release  was  on
average  35:1,  this  ratio  decreasing  considerably  in
the  patients  with  hypersensitivity  pneumonitis
(ratio,  4:1)  and  being  lower  in  the  patients  with
sarcoidosis (ratio, 16:1).
Finally,  the  initial  spontaneous  release  of  IL-8
ranged  between  1861  and  6390pg/106 AMs,  being
maximum  in  the  group  with idiopathic pulmonary
fibrosis.  The  relationship  between  basal  secretion
in  culture  and  initial  spontaneous release  was on -
average  125-fold,  this  being  lower  in  the  group
of  hypersensitivity  pneumonitis  patients  (ratio,
64:1).
Determination of the type of stimulus and most
effective concentration on the secretion of
inflammatory cytokines
Three  classic  stimuli  (lipopolysaccharide,  phorbol-
myristate  acetate and  gamma-interferon)  were  eval-
uated at three different concentrations. Overall, the
results obtained (not shown) indicated that the most
important  stimulus  of  cytokine  secretion  was  LPS.
Regarding  the  most  stimulatory  concentration,  the
overall data indicated that, for this stimulus,  it was
10m g/ml. Considering all four cytokines globally, the
most stimulatory concentrations of phorbolmyristate
acetate  and  gamma-interferon  were  respectively
10–6 M and 100U/ml. Figure 1 shows the results of a
typical case.
Secretion of inflammatory cytokines under
conditions of stimulation
In Figs 2–5 are represented the results of the basal
and  stimulated  macrophage  secretion  of  the  four
inflammatory cytokines studied.
Overall comparison of the secretion of the different
cytokines revealed that under basal conditions AMs
secrete low amounts of IL-1b (in the 10–200pg/106
cells range), higher amounts of TNF-a and IL-6 (in the
1–10ng/106 cells range) and large amounts of IL-8 (in
the 150–1000ng/106 cells range).
Statistical study of the effect of the different stimuli
on the secretion of all the cytokines studied disclosed
statistically  significant  differences  (Wilcoxon  test)
between basal secretion and secretion stimulated by
LPS  or  phorbolmyristate  (P<0.008  in  all  cases).
However,  no  significant  differences  between  basal
secretion  and  secretion  stimulated  by  gamma-inter-
feron were observed.
On comparing the secretion induced by  LPS and
phorbolmyristate, statistically  significant  differences
(Wilcoxon test P<0.004 in all cases) were observed
J. E. Losa Garc´ õ a et al.
46 Mediators of Inflammation · Vol 8 · 1999

















Control (n = 4) 0.24 0.05 95.7 0.7 3.5 0.6 0.7 0.5 0 0
Sarcoidosis (n = 5) 0.38 0.07 70.6 5.6 26.6 5.6 1.4 0.5 1.2 0.9
HP (n = 3) 0.71 0.22 35.3 11.6 53.6 0.9 9.0 7.5 2.0 0.6
IPF (n = 5) 0.40 0.21 84.0 5.9 3.6 1.4 9.0 2.3 3.4 0.7
Abbreviations: HP = hypersensitivity pneumonitis; IPF = idiopathic pulmonary fibrosis; SEM = standard error of mean.
FIG.  1.  Effect  of  concentration  and  type  of  stimulus  on
cytokine secretion by alveolar macrophages (representative
case). The most potent stimulus of TNF-a secretion by AM
was  LPS  at  a  concentration  of  10m g/ml.  Definition  of
abbreviations: AM = alveolar macrophage, IFN = interferon,
LPS = lypopolysaccharide, PMA = phorbolmyristate.Inflammatory cytokines and alveolar macrophages
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FIG. 2. Interleukin-1b secretion in the different experimental
groups. Statistical study of the effect of the different stimuli
on IL-1b secretion by AMs revealed significant differences
(Wilcoxon test) between basal secretion and that stimulated
by  LPS  (P<0.001)  or  by  phorbolmyristate  (P=0.001).  No
significant differences were observed between basal secre-
tion  and  that  elicited  by  interferon.  On  comparing  LPS-
induced secretion with that induced by PMA, the existence of
statistically significant differences was observed (Wilcoxon
test,  P=0.001).  Comparison  among  the  different  groups
did  not  reveal  significant  differences  under  either  basal
or  stimulated  conditions.  Definition  of  abbreviations:
AM  =  alveolar  macrophage,  HP  =  hypersensitivity  pneu-
monitis,  IPF  =  idiopathic  pulmonary  fibrosis,  IFN  =
interferon, IL = interleukin, LPS = lipopolysaccharide, PMA,
phorbolmyristate.
FIG. 3. Tumour necrosis  factor-a secretion  in the different
experimental groups. Study of the effect of different stimuli
on TNF-a secretion by AMs revealed statistically significant
differences (Wilcoxon test, P<0.001 for LPS and P=0.002 for
PMA). No significant differences were found between basal
and  interferon-induced  secretion.  Comparison  of  LPS-
induced  and  PMA-induced  secretion  revealed  statistically
significant differences (Wilcoxon test, P=0.001). Comparison
among the different groups study did not disclose significant
differences  under  either  basal  or  stimulated  conditions.
Definition of abbreviations: AM = alveolar macrophage, HP =
hypersensitivity  pneumonitis,  IPF  =  idiopathic  pulmonary
fibrosis,  IFN  = interferon, LPS = lipopolysaccharide, PMA,
phorbolmyristate, TNF = tumour necrosis factor.
FIG. 4. Interleukin-6 secretion in the different experimental
groups.  Study  of  the  effect  of  different  stimuli  on  IL-6
secretion by AMs revealed statistically significant differences
(Wilcoxon test, P=0.001 for LPS and P=0.008 for PMA). No
significant differences were found between basal and inter-
feron-induced  secretion.  Comparison  of  LPS-induced  and
PMA-induced secretion revealed statistically significant dif-
ferences (Wilcoxon test,  P=0.003). Comparison among the
different groups study did not disclose significant differences
under  either  basal  or  stimulated  conditions.  Definition  of
abbreviations:  AM  =  alveolar  macrophage,  HP  =  hyper-
sensitivity pneumonitis, IPF = idiopathic pulmonary fibrosis,
IFN = interferon, IL = interleukin, LPS = lipopolysaccharide,
PMA, phorbolmyristate.
FIG. 5. Interleukin-8 secretion in the different experimental
groups. Statistical study of the effect of the different stimuli
on  IL-8  secretion  by  AMs  revealed significant  differences
(Wilcoxon test) between basal and LPS-stimulated secretion
(P<0.001)  or  secretion  stimulated  by  PMA  (P=0.004).  No
significant differences between basal and interferon-induced
secretion were observed. On comparing LPS-induced secre-
tion  and  that  induced  by  PMA,  statistically  significant
differences  were  found  (Wilcoxon  test,  P=0.004). Compar-
ison of the different groups revealed significant differences
in  LPS-stimulated  secretion  (P=0.025).  These  differences
were observed between the patients with IPF and the other
groups (Fisher PLSD test P<0.05). Definition of abbreviations:
AM  =  alveolar  macrophage,  HP  =  hypersensitivity  pneu-
monitis,  IPF  =  idiopathic  pulmonary  fibrosis,  IFN  =
interferon, IL = interleukin, LPS = lipopolysaccharide, PMA,
phorbolmyristate.for all the cytokines studied. Accordingly, with respect
to cytokine-stimulated secretion, in all cases the most
potent stimulus was found to be LPS, thus confirming
preliminary results.
Comparison  of  the  different  groups  studied  as
regards  inflammatory  cytokine  secretion  did  not
reveal significant  differences in any of  them, under
either basal or stimulated conditions, with the excep-
tion  of  IL-8 secretion stimulated  by  LPS. Regarding
this, the global  differences (ANOVA P=0.025)  were
due  to  the  differences  between  the  patients  with
idiopathic pulmonary fibrosis and the other groups
(Fisher PLSD test P<0.05).
Finally, we evaluated the mean increase in secretion
induced by the chemical stimuli. In the case of LPS,
this was seen to elicit an approximately 60-fold mean
increase in the release of IL-1b ; a 30-fold increase in
that of TNF-a ; a 20-fold increase in that of IL-6 and a
three-fold  increase  in  the  release  of  IL-8,  all  with
respect to basal values. However, this mean increase
differed depending on the group studied and the type
of  cytokine  in  question. Thus, in  the case of  IL-1b
release  by  LPS  stimulation  the  effect  was  much
greater  in  the  control  and  IPF  groups  than  in  the
groups of granulomatous diseases. Moreover, regard-
ing the increase in TNF-a and IL-8 secretion by LPS the
effect was much stronger in the IPF group than in the
other  groups. With  respect  to  the  increase  in  IL-6
secretion by LPS the effect was much greater in the
control than in the other groups. Finally, phorbolmyr-
istate only elicited significant increases in the secre-
tion of IL-1b (tripling its release).
Measurement of cytokines in brochoalveolar
lavage fluid
Cytokine secretion in culture is a widely used method
for evaluating AMs in functional terms. However, the
complex interplay of interactions among the inflam-
matory  cytokines (inducer  or suppressor  effects  of
one cytokine against another) make it necessary to
evaluate  the  net  effect  of  these cytokines in  vivo.
Accordingly, the concentrations of the four inflamma-
tory cytokines were measured in the BAL fluid. Table
2 shows the mean values. The results were expressed
in pg/ml of fluid recovered since normalization of the
results using albumin as denominator has no biolog-
ical meaning because the cytokines studied here are
not present in the circulating blood of the patients
included in the different groups.
Regarding  the  measurement  of  IL-1b in  the  BAL
fluid, this cytokine was only detected in one of the
four control cases (1.26pg/ml); in none of the cases
of  sarcoidosis;  in  two  out  of  the  three  cases  of
hypersensitivity  pneumonitis  (1.90  and  3.82pg/ml)
and in two of the five cases of idiopathic pulmonary
fibrosis (0.87 and 3.95pg/ml).
TNF-a was detected in the BAL fluid in one of the
four  control cases  (0.20pg/ml);  in  all  the  cases  of
sarcoidosis (mean: 2.6pg/ml; SEM: 0.72);  in two of
the three cases of hypersensitivity pneumonitis (1.40
and  3.80pg/ml)  and  in  three  of  the  five  cases  of
idiopathic pulmonary fibrosis (0.60, 2.20 and 2.21pg/
ml).
In the BAL fluid, IL-6 was detected in one out of the
four  control cases  (0.57pg/ml);  in  two  of  the  five
cases of sarcoidosis (2.24 and 2.25pg/ml), in all the
cases  of  hypersensitivity  pneumonitis  (mean:
19.21pg/ml;  SEM:  12.68)  and  in  all  the  cases  of
idiopathic  pulmonary  fibrosis  (mean:  4.98pg/ml;
SEM: 1.98).
Finally, in most of the BAL fluids studied (15 out of
17) the presence of IL-8 was detected. This magnitude
was  distributed  normally. The  inferential  statistical
study  (ANOVA)  did  not  reveal  significant  overall
between-group differences.
Discussion
Basic aspects of the experimental study
Selection of the subjects studied here was based on
criteria  unanimously  accepted  in  the  literature.  In
particular, the AMs from healthy controls and those
from patients with three classic types of lung disease:
sarcoidosis,  hypersensitivity  pneumonitis  and  idio-
pathic pulmonary fibrosis. The clinical characteristics
together with the data on the BAL of the cases studied
were similar to those reported in the literature.
Once the present study had been judged suitable,
the next step was to standardize the characteristics of
cell  culture  and  the  concentrations  of  the  most
J. E. Losa Garc´ õ a et al.
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Control (n = 4) 0.3 0.3 0.1 0.1 0.1 0.1 112.6 80.1
Sarcoidosis (n = 5) 0 0 2.6 0.7 0.9 0.5 34.2 15.7
HP (n = 3) 1.9 1.1 1.7 1.1 19.2 12.7 279.8 129.8
IPF (n = 5) 1 0.8 1 0.5 5 2 252.2 106.8
Abbreviations: HP = hypersensitivity pneumonitis; IL = interleukin; IPF = idiopathic pulmonary fibrosis; SEM = standard
error of mean; TNF = tumour necrosis factor. Invest 1990; 86: 1556–1564.appropriate  stimuli  for  the  induction  of  cytokine
secretion. Throughout the study, we chose a culture
model  that  used  purified  AMs.  AM  purification
required  three  successive  steps.  First,  the  mono-
nuclear fraction (macrophages and lymphocytes) was
separated of neutrophils, erythrocytes, cellular detri-
tus  and  dead  cells  by  a  density  gradient,  already
reported in the literature for the separation of AMs.1
The  next  step,  to  separate AMs  from  lymphocytes,
made  used  of  the  capacity  of  AMs  to  adhere  to
polystyrene dishes. Both methods permit direct study
of cytokine production by AMs. However, the results
obtained should be interpreted with caution because
adherence itself is able to stimulate the production of
these type of inflammatory mediators.5 In our opin-
ion,  the  other option–study  of ‘fresh’,  unseparated
cells–had more drawbacks as regards interpretation
of the results.
Initial spontaneous release of cytokines
Taking the foregoing data into account, we observed
that during the adherence time the AMs secreted very
small amounts of the cytokines in comparison with
basal  secretion in  later  culture,  indicating  that this
initial  release  could  be  discarded  in  the  overall
evaluation of the results. On comparing initial sponta-
neous release among the different groups, in all the
cytokines studied the maximum values were found in
the group with idiopathic pulmonary fibrosis, reflect-
ing previous stimulation of the macrophages in vivo.
Another aspect that can be interpreted in the same
sense was the low relationship between initial sponta-
neous release of IL-6 and IL-8 and their basal secretion
during prolonged culture in the patients with granulo-
matous  disease.  Finally,  the  relationship  between
basal  secretion  in  culture  and  initial  spontaneous
release was much higher for IL-8, intermediate for IL-6
and low for TNF-a , suggesting that adherence to the
plastic  support is  a  very  important stimulus  in  the
secretion of IL-8 and, to a lesser extent, that of IL-6.
Accordingly, from these data it may be concluded that
in interstitial lung disease AMs are primed in vivo for
the  secretion  of  inflammatory  cytokines  and  that
adherence  itself  strongly  induces  the  secretion  of
these  molecules.  In  an  exhaustive  review  of  the
literature,  we  have  found  no  reference  to  initial
spontaneous release such that no data are available for
comparative purposes.
Type and concentration of stimulus
After the scant initial release had been confirmed, the
next  aspect  to  be  evaluated  was  the  type  and
concentration  of  the  agents  that  would  exert  a
maximum  effect  for  the  secretion  of  the  different
inflammatory  cytokines. The  results  obtained  indi-
cated that the most potent stimulus was LPS. This is
consistent with most reports in the literature. Regard-
ing the concentration of this agent, maximum stimula-
tion  of  cytokine  production  was  achieved  with
10m g/ml, a concentration identical to that used by
other authors.8,9 Phorbolmyristate (PMA), at all con-
centrations studied, had a less potent effect than LPS,
although it did elicit a larger increase in the secretion
of  the  cytokines  with  respect  to  basal  conditions.
However, at all concentrations studied gamma-inter-
feron was unable to increase the secretion of these
molecules. These findings are similar to those repor-
ted in the literature showing that PMA stimulates IL-
1,2 and TNF-a 10 secretion  while  gamma-interferon
either  fails  to  affect  secretion11 or  exerts  a  co-
stimulant effect on other substances,11 although other
authors  have  reported  a  stimulatory  effect.10,12
Accordingly, LPS at a final concentration of 10m g/ml
was chosen as the best stimulus in the evaluation of
cytokine secretion.
Basal and stimulated secretion of cytokines by
alveolar macrophages
The  results  obtained  can  be  grouped  into  several
different aspects.
First,  with  all  the  cytokines  studied,  the  most
homogeneous  group  was  found  to  be  the  control
group,  considerable  variability  being  found  in  the
other groups. The latter phenomenon can be attrib-
uted  to  the  fact that we were  studying  patients in
different disease stages with different developmental
forms  (inactive  or  active).8 This  variability  in  the
secretion of cytokines has been documented by other
authors13 and  has  been attributed to  the  heteroge-
neous  secretion  capacity  of  AMs  themselves.1,2,13
Another  factor  to  be  considered  is  that  cytokine
secretion  by  AMs  may  differ  within  the  lungs
themselves.14
Second,  in  all  cases  basal  secretion  of  all  the
inflammatory cytokines was demonstrated, although
the degree of release was different in each one. Thus
AMs  secrete  small  amounts  of  IL-1b ,  moderate
amounts of TNF-a and IL-6 and high amounts of IL-8.
This type of cytokine profile has been reported by
other authors5 and has been interpreted in terms of
the notion that in the healthy lung aggressive agents
will  give  rise  to  inflammatory  responses  at  the
expense of large amounts of IL-6 and TNF-a and only
limited  amounts  of  IL-1.15 By  contrast,  agents  that
elicit  a  recruitment  of  monocytes  to  the  lung  will
induce  a  strong  production  of  IL-1  and  will  thus
facilitate  the  synergic  action  of  this  cytokine  with
TNF-a and  IL-6,  the  local  inflammatory  response
being enhanced.15 Evaluation of the concentration of
the different inflammatory cytokines in the BAL fluid
afforded  the  same  pattern  of  cytokine  secretion,
suggesting that to a certain extent secretion in culture
would be similar to that taking place in vivo.
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lated secretion of the different cytokines are compara-
ble with those described in the literature as regards
ELISA measurement in  culture supernatants. In this
sense, the spontaneous secretion of cytokines in the
control group  was similar  to that reported by Tho-
massen  et  al.16 but  higher  than  that  reported  by
Standiford et al.,6,17,18Agostini et al.9 and Homolka19.
The cytokine concentration range in the AM super-
natant of control subjects stimulated with LPS affor-
ded somewhat discrepant results with respect to the
literature. In particular, IL-1b levels of between 0.350
and 50ng/106 AMs have been reported8,16,20–26 while
in  this  study  a  mean  value  of  3.6ng/106 AMs  was
found. Stimulated secretion of TNF-a in the literature
ranges between 5 and 100ng/106 AMs,8,9,16,21,23,26,27
while in this study a mean value of 45ng/106 AMs was
found. Regarding the stimulated secretion of IL-6, the
literature contains few references, pointing to a range
of 0.2–87ng/106 AMs,8,9,15,16,19,25 while in this study
a mean value  of  63ng/106 AMs  was  found.  Finally,
stimulated  IL-8  release  in  the  control  group  was
692ng/106 AM,  higher  than  that  reported  in  the
literature (10–500ng/106 AMs).17,18,28,29
The quantitative data on the production of inflam-
matory  cytokines  in  interstitial  lung  diseases  are
more limited than those available for controls. The
results obtained concerning the basal and stimulated
secretion  of  cytokines  by AMs  from  patients  with
sarcoidosis point to both discrepancies and similar-
ities  with  those referred  to  in  the  literature. Thus,
our data are similar to those reported by the team of
M¨ uller-Quernheim19,30 but differ from those of Stef-
fen  et  al.8 and  Nakamura  et  al..26 We  can  only
compare  the  results  obtained  in  the  groups  of
patients  with  hypersensitivity  pneumonitis  with
respect  to  IL-8  secretion,31 since  the  only  studies
carried out  on  the  production of  cytokines in  this
process  have  used  bioassays  to  measure  IL-1  and
TNF.32 Our results on the quantification of the AM-
mediated basal  and  stimulated  secretion of  IL-8  by
AMs  of  patients  with  hypersensitivity  pneumonitis
differ considerably from those reported by Denis.31
Finally, in idiopathic pulmonary  fibrosis the data in
the literature about the evaluation of cytokine secre-
tion  by  immunoassay  are  scanty.26,33 In  this  sense,
our results  differ  from  those of  Nakamura26 and in
comparison with  those reported by  Zhang  et  al.33
they  are  similar  with  respect  to TNF-a but  differ
with respect to IL-1b . In no case have we found any
references  to  IL-6  production  by  AMs  in  patients
with idiopathic pulmonary fibrosis.
Fourthly, between-group comparison of the secre-
tion of the different types of cytokine did not reveal
global significant differences with the exception of
stimulated  IL-8  release.  Detailed  analysis  of  the
differences revealed that the group with the greatest
production of this cytokine included the patients with
idiopathic pulmonary  fibrosis.  Our  data differ  from
some  appearing  in  the  literature  pointing  to  an
increase in  the release of  these  inflammatory cyto-
kines in sarcoidosis,8,19,26,34 hypersensitivity pneumo-
nitis31,32 and  idiopathic pulmonary  fibrosis13,26,33,35
with  respect  to  controls.  Several  reasons  may  be
invoked to account for the discrepancy between our
data and these studies.8 Firstly, the number of subjects
in each group is low and probably, although diagnosis
was correct, there would be differences in the degree
of  activity  or  in  the  developmental  stage  of  the
diseases.  Secondly,  not  all  the  authors  referred  to
above  used  immunoassay  as  the  determination
method, hence limiting comparisons. Additionally, the
sensitivity of  each immunoassay may  differ. Thirdly,
different AM culture techniques may have been used.
Despite these observations, in another series of works
on AM cytokine secretion results similar to our own
have been reported.19,26,36 The increase in the secre-
tion of IL-8 in the group of patients with idiopathic
pulmonary  fibrosis–also recently reported by  Naka-
mura  et  al.26–which  may  be  involved  to  a  more
important extent in the recruitment of neutrophils to
the  lung,  should  also  be  noted;  this  finding  is
characteristic  in  the  BAL  fluid  of  this  group  of
patients.26,37,38 Currently, the central role of IL-8 in
the  pathogenesis  of  this  disease  seems
unquestionable.26,38
Finally,  we  stress  that  the  increase  in  secretion
induced  by  stimulation  with  LPS  varies  for  each
cytokine  and  among  the  different  groups.  In  this
sense, the increase is maximum in IL-1b and TNF-a ,
suggesting  that  in  the  case  of  cytokines  being
produced intensely  in vivo (e.g.  IL-8) an additional
stimulus  would  elicit  a  slight  increase  in  release.
Moreover,  in  controls  and  patients  with  idiopathic
pulmonary fibrosis the endotoxin is able to increase
IL-1b secretion to a considerable degree, this increase
being much less pronounced in patients with sarcoi-
dosis  and  pneumonitis.  Presumably,  this  could  be
interpreted in terms of the idea that AMs would be
stimulated  in  vivo.  The  decrease  in  the  secretory
response of inflammatory interleukins to stimulation
with LPS in AMs that under basal conditions secrete
large  amounts  has  been described in  patients with
pneumonia.14 This  tolerance  to  the  endotoxin  is
interpreted  as  a  homeostatic  response  whose  aim
would  be to limit  local inflammatory response and
hence  lung  damage.14 Other  authors  have  demon-
strated  that  the AMs  of  patients  with  ILD  can  be
primed in vivo to produce large amounts of cytokines
(IL-1) when stimulated in vitro.39
The following conclusions can be drawn from this
work. The pattern of inflammatory cytokine secretion
by AMs differs from that of others cells belonging to
the  MPS. Thus, AMs  secrete  low  amounts  of  IL-1;
moderate amounts of TNF and IL-6, and high amounts
of  IL-8. Adherence is  an  important  stimulus  in  the
J. E. Losa Garc´ õ a et al.
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increase  in  the  inverse  sense  to  basal  secretion.
Considerably  individual  variability  exists  as  regards
the secretion of inflammatory cytokines by the AMs of
patients with interstitial lung disease and the AMs of
these patients are primed in vivo for the secretion of
these cytokines. The results of our study, performed
in  vitro,  could  be  extrapolated  to  the  in  vivo
setting.
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